Tweet
FRANCE 24
<img alt="" height="1" width="1" />
Glaxo drug shown to extend lives of ovarian cancer patients
Reuters
By Deena Beasley. CHICAGO, June 1 | Sat Jun 1, 2013 4:59pm IST. CHICAGO, June 1 (Reuters) - A cancer drug sold by GlaxoSmithKline was shown in a clinical trial to extend survival by several months for ovarian cancer patents whose disease had ...
Kidney drug may help hold off relapse of ovarian cancerMinneapolis Star Tribune
Drug Used to Treat Kidney Cancer May Hold Off Relapses of Ovarian CancerNew York Times
Maintenance pazopanib extends DFS in women with advanced ovarian cancerHealio
MedPage Today -U.S. News & World Report -Medscape
all 15 news articles »
More...